NPR Nationally Syndicated Feature Wednesday July 8: 'What's Behind the Push to Make Peptide Therapies More Readily Available' — RFK Jr. Cited Peptide Benefits on Joe Rogan Earlier This Year, Institute for Safe Medication Practices Warned 'These Peptides Really Do Not Have Established Effectiveness, So the Only Thing You Have Is Risk,' and NPR Reported That Many PCAC Members Have Ties to the Peptide Industry and Work for Clinics That Offer Injectable Peptides
NPR published a nationally syndicated feature Wednesday July 8, 2026 on the FDA effort to expand compounding-pharmacy access to popular peptides including TB-500, BPC-157, and MOTS-c ahead of the July 23-24 PCAC vote. The reporting placed three lines side by side: HHS Secretary Robert F. Kennedy Jr. extolled peptide benefits in a Joe Rogan interview earlier this year and promised to reverse Biden-era restrictions preventing US compounding pharmacies from making them; the Institute for Safe Medication Practices told NPR 'these peptides really do not have established effectiveness, so the only thing you have is risk'; and NPR noted many members of the FDA advisory committee have ties to the peptide industry and work for clinics that offer injectable peptides. The piece syndicated across dozens of member stations (KUAF, NSPR, WLRN, Prairie Public, HPPR, WVXU, KALW, WKNO, KUNC among them), pushing the panel-composition story past trade press (Endpoints, STAT, FiercePharma) and academic-scientist voices (Knoepfler in Washington Post) into general-audience mainstream media two weeks before the vote.